Clinical trial
An Open Label Study of RFH Therapy as Treatment for CL Caused by Leishmania Tropica in India
NCT01661296 is registered in ClinicalTrials.gov with Sarder Patel Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Study of RFH Therapy as Treatment for CL Caused by Leishmania Tropica in India
- Lead sponsor
- Sarder Patel Medical College
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- December 31, 2011
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous leishmaniasis